Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Carrie Strand

机构:Mayo Clinic, Alliance for Clinical Trials in Oncology, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID:0000-0001-7820-6138

发表论文 163 篇 · 总被引 895 次 · h-index 12

代表论文

  • Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer (2026 · New England Journal of Medicine · 被引 22)
  • Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis (2026 · Cancer Prevention Research · 被引 2)
  • Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy (2026 · Annals of Surgical Oncology · 被引 1)
  • Data from Was It Worth It? Response Data from >650 US and International Participants in Chemoprevention Trials (2026 · 被引 1)
  • Supplementary Figure S4 from Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis (2026)
  • Supplementary Table S4 from Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis (2026)